MAPT and Alzheimer disease: In contrast, in the intermediate group, we saw a significant increase in the number of neurons labeled with pTau in the subiculum, CA1, CA2, and DG regions, consistent with previous studies on tau pathology in postmortem AD cases [37, 38, 54, 55].